TrialJournal of translational medicine2015

Improved Natural Killer cell activity and retained anti-tumor CD8(+) T cell responses contribute to the induction of a pathological complete response in HER2-positive breast cancer patients undergoing neoadjuvant chemotherapy.

E Muraro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.